Q1 Earnings Estimate for Stereotaxis Issued By Roth Capital

Stereotaxis, Inc. (NYSEAMERICAN:STXS) – Analysts at Roth Capital reduced their Q1 2025 EPS estimates for Stereotaxis in a research note issued to investors on Tuesday, March 4th. Roth Capital analyst J. Wittes now anticipates that the company will post earnings per share of ($0.07) for the quarter, down from their previous forecast of ($0.01). The consensus estimate for Stereotaxis’ current full-year earnings is ($0.26) per share. Roth Capital also issued estimates for Stereotaxis’ Q2 2025 earnings at ($0.08) EPS, Q4 2025 earnings at ($0.08) EPS, FY2025 earnings at ($0.30) EPS and FY2026 earnings at ($0.07) EPS.

Stereotaxis Stock Down 2.2 %

Shares of STXS opened at $1.81 on Thursday. The company has a market capitalization of $153.36 million, a P/E ratio of -6.46 and a beta of 1.54. The firm’s 50 day moving average price is $2.27. Stereotaxis has a twelve month low of $1.66 and a twelve month high of $3.29.

Institutional Investors Weigh In On Stereotaxis

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. ProShare Advisors LLC boosted its holdings in Stereotaxis by 53.6% in the fourth quarter. ProShare Advisors LLC now owns 15,913 shares of the company’s stock worth $36,000 after purchasing an additional 5,556 shares during the last quarter. Two Sigma Securities LLC purchased a new position in shares of Stereotaxis during the 4th quarter worth $54,000. SG Americas Securities LLC boosted its stake in shares of Stereotaxis by 39.2% during the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock worth $60,000 after acquiring an additional 7,417 shares during the last quarter. Jane Street Group LLC boosted its stake in shares of Stereotaxis by 26.9% during the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after acquiring an additional 6,313 shares during the last quarter. Finally, Wells Fargo & Company MN boosted its stake in shares of Stereotaxis by 53.7% during the 4th quarter. Wells Fargo & Company MN now owns 26,915 shares of the company’s stock worth $61,000 after acquiring an additional 9,403 shares during the last quarter. Hedge funds and other institutional investors own 45.35% of the company’s stock.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.